Researchers identify gene set that shows which patients benefit from chemo after surgery
Tuesday, September 7, 2010 - 16:28
in Health & Medicine
Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ("adjuvant chemotherapy").